Xiangyu Medical Co. Ltd. A - Asset Resilience Ratio

Latest as of September 2025: 1.53%

Xiangyu Medical Co. Ltd. A (688626) has an Asset Resilience Ratio of 1.53% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Xiangyu Medical Co. Ltd. A for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥50.18 Million

≈ $7.34 Million USD Cash + Short-term Investments

Total Assets

CN¥3.27 Billion

≈ $478.83 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2023)

This chart shows how Xiangyu Medical Co. Ltd. A's Asset Resilience Ratio has changed over time. See Xiangyu Medical Co. Ltd. A net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Xiangyu Medical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688626 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥50.18 Million	1.53%
Total Liquid Assets	CN¥50.18 Million	1.53%

Asset Resilience Insights

Limited Liquidity: Xiangyu Medical Co. Ltd. A maintains only 1.53% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Xiangyu Medical Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Xiangyu Medical Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Vitrolife AB ST:VITR	Medical Devices	7.27%
Medprin Regenerative Medical Technologies Co. Ltd. SHE:301033	Medical Devices	19.31%
Tellgen Corp SHE:300642	Medical Devices	8.60%
Lumos Diagnostics Holdings Ltd AU:LDX	Medical Devices	9.40%
T&R Biofab Co. Ltd KQ:246710	Medical Devices	0.12%
Ok Biotech Co Ltd TW:4155	Medical Devices	0.32%
Promimic AB ST:PRO	Medical Devices	8.62%
Memphasys Ltd AU:MEM	Medical Devices	0.00%

Annual Asset Resilience Ratio for Xiangyu Medical Co. Ltd. A (2021–2023)

The table below shows the annual Asset Resilience Ratio data for Xiangyu Medical Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	6.26%	CN¥162.19 Million ≈ $23.73 Million	CN¥2.59 Billion ≈ $379.31 Million	-20.62pp
2022-12-31	26.88%	CN¥636.47 Million ≈ $93.14 Million	CN¥2.37 Billion ≈ $346.52 Million	-2.82pp
2021-12-31	29.70%	CN¥648.14 Million ≈ $94.84 Million	CN¥2.18 Billion ≈ $319.38 Million	--

pp = percentage points

About Xiangyu Medical Co. Ltd. A

SHG:688626 China Medical Devices

Market Cap

$1.37 Billion

CN¥9.38 Billion CNY

Market Cap Rank

#7739 Global

#1905 in China

Share Price

CN¥58.64

Change (1 day)

+1.38%

52-Week Range

CN¥35.50 - CN¥87.12

All Time High

CN¥116.87